Century Therapeutics (IPSC) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $81.6 million.
- Century Therapeutics' Other Gross PP&E Adjustments rose 2154.76% to $81.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.6 million, marking a year-over-year increase of 2154.76%. This contributed to the annual value of $66.9 million for FY2024, which is 778.9% down from last year.
- As of Q3 2025, Century Therapeutics' Other Gross PP&E Adjustments stood at $81.6 million, which was up 2154.76% from $69.0 million recorded in Q2 2025.
- Century Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $81.6 million for Q3 2025, and its period low was $53.4 million during Q2 2022.
- Over the past 4 years, Century Therapeutics' median Other Gross PP&E Adjustments value was $68.9 million (recorded in 2024), while the average stood at $69.1 million.
- Per our database at Business Quant, Century Therapeutics' Other Gross PP&E Adjustments soared by 4718.4% in 2023 and then tumbled by 1327.35% in 2024.
- Over the past 4 years, Century Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $65.9 million in 2022, then grew by 10.12% to $72.5 million in 2023, then dropped by 7.79% to $66.9 million in 2024, then rose by 22.02% to $81.6 million in 2025.
- Its Other Gross PP&E Adjustments was $81.6 million in Q3 2025, compared to $69.0 million in Q2 2025 and $68.1 million in Q1 2025.